Submitted by Anonymous (not verified) on 7 May 2025 - 12:58
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 8, Status: Authorised